UTZ Investor Reminder: Utz Brands Investigation over $14.25 per share Transaction is Ongoing – Contact BFA Law if You Hold Shares

NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the take-private merger of Utz Brands, Inc. (NYSE: UTZ), through which the founding Rice and Lissette family (through various entities) will own 50% of the post-merger company.

If you are a current shareholder of Utz Brands, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/utz-brands-investigation.

Key Details of the Utz Brands ($UTZ) Investigation:

  • Investigation Overview: Breaches of Fiduciary Duty in connection with Intersnack Group’s offer to acquire Utz Brands for $14.25 per share.
  • Action: Contact BFA Law to discuss your rights

Why is the Utz Brands Transaction being Investigated?

On July 21, 2026, Utz announced that it had entered into a definitive agreement under which Intersnack Group will acquire all Utz Class A Common Stock for $14.25 per share in cash. As a part of the merger, the Rice and Lissette family (as well as certain affiliates) have agreed to vote shares representing approximately 42% of Utz’ common stock in favor of the transaction.

After the merger, the Rice and Lissette family group will own 50% of the post-merger company, representing an approximate 8% gain in their collective ownership. Public shareholders, who are being asked to vote to approve the transaction, have not had the same opportunity to roll their shares into the post-merger entity.

BFA is investigating whether the negotiation or terms of the merger may represent a breach of fiduciary duty by any of Utz’ directors, or by the Rice and Lissette family as potential controllers of the corporation.

Click here for more information:


https://www.bfalaw.com/cases/utz-brands-investigation
  

What Can You Do?

If you are a current holder of Utz stock, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/utz-brands-investigation

Or contact:

Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.” 

Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/utz-brands-investigation

Attorney advertising. Past results do not guarantee future outcomes.



MGM Investor Reminder: MGM Resorts Investigation over $48.30 per share Offer is Ongoing – Contact BFA Law if You Hold Shares

BFA Law is investigating Barry Diller’s $48.30 per share offer to acquire MGM Resorts International; current shareholders are notified to contact the firm.

NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating Barry Diller’s bid to buy MGM Resorts International (NYSE:MGM). MGM is incorporated in Delaware.

Barry Diller is a member of MGM’s board of directors. People, Inc. (“People,” f/k/a/ IAC, Inc.), a company that Diller founded and controls, is MGM’s largest single stockholder. On June 1, 2026, People made an unsolicited bid to buy the remaining MGM stock for $48.30 per share.

If you are a current shareholder of MGM, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/mgm-resorts-investigation.

Key Details of the MGM ($MGM) Investigation:

  • Investigation Overview: Breaches of Fiduciary Duty in connection with Barry Diller’s offer to acquire the remaining stock of MGM for $48.30 per share
  • Action: Contact BFA Law to discuss your rights

Why is the MGM Transaction being Investigated?

As a director, Diller owes fiduciary duties to MGM and its stockholders. People also recently entered a governance agreement with MGM that gave People the right to designate two MGM directors going forward.   Because Diller “stands on both sides” of the proposed deal, and because other MGM fiduciaries could potentially receive benefits that other stockholders do not receive, these facts create a create conflicts of interest under Delaware law. If MGM and Diller reach an agreement, they must comply with Delaware’s strict requirements for “cleansing” these conflicts and ensuring the deal is fair to MGM’s stockholders.

In a news release on June 1, MGM stated that the board of directors “will carefully review and consider the proposal to determine the course of action that it believes is in the best interests of the Company and all of its shareholders.”  

BFA is investigating whether the potential agreement complies with Delaware law.

Click here for more information:


https://www.bfalaw.com/cases/mgm-resorts-investigation

What Can You Do?

If you are a current holder of MGM stock, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/mgm-resorts-investigation

Or contact:

Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”

Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/mgm-resorts-investigation

Attorney advertising. Past results do not guarantee future outcomes.



HUBG Investor Reminder: Hub Group Securities Fraud Class Action over 18% Stock Drop is Ongoing – Contact BFA Law before August 28 Deadline

BFA Law has filed a securities fraud class action lawsuit on behalf of Hub Group investors after its stock plummeted 18% after it announced its financial statements were materially misstated and should no longer be relied upon

NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Hub Group Inc. (NASDAQ:HUBG) and certain of the Company’s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.

If you invested in Hub Group, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/hub-group-class-action-lawsuit.

Key Details of the HUBG ($HUBG) Class Action:

  • Lead Plaintiff Deadline: August 28, 2026
  • Alleged Misconduct: Securities fraud relating to Hub Group’s financial results, revenue recognition, accounting of costs, internal controls, and prospects for/drivers of growth
  • Largest Stock Drop: February 6, 2026 – 18% Stock Drop
  • Court: U.S. District Court for the Northern District of Illinois
  • Filing Law Firm: Bleichmar Fonti & Auld (“BFA Law”)
  • Action: Contact BFA Law to discuss your rights

Investors have until August 28, 2026, to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Hub Group securities. The class action is pending in the U.S. District Court for the Northern District of Illinois. It is captioned Lawler v. Hub Group, Inc., No. 1:26-cv-07596.

Why is Hub Group Being Sued for Securities Fraud?

Hub Group is a transportation and logistics freight carrier that provides trucking and related services to operators across the supply chain. Hub Group services a customer base extending across various industries, including retail, consumer products, automotive, and durable goods, and reports to be one of the largest freight transportation providers in North America. 

The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements concerning the premature and incorrect revenue recognition of certain transactions, the understatement of purchased transportation costs and accounts payable, the effectiveness of internal controls, and the Hub Group’s drivers of financial results and growth.

Why did Hub Group’s Stock Drop?

On February 5, 2026, Hub Group announced that the Company’s financial statements for the first three quarters of 2025 should not be relied upon and would be restated due to “an error that resulted in the understatement of purchased transportation costs and accounts payable in the first nine months of 2025.” Hub Group revealed that its reports for those quarters “were in each case materially misstated due to the aforementioned error and should no longer be relied upon” and that “the Company [wa]s also continuing to assess the effectiveness of its disclosure controls and procedures and internal control over financial reporting and appropriate remediation steps.”  Hub Group also estimated that “[t]he total amount of the reduction to accounts payable and purchased transportation costs related to this issue that was recorded during these periods is $77 million.”  

This news caused the price of Hub Group stock to decline roughly 18%, from $51.33 per share at close on February 5, 2026, to $41.96 per share at close on February 6, 2026.

On May 12, 2026, Hub Group announced that it had “identified certain transactions that were prematurely or incorrectly recognized or not adequately supported,” causing its 2023 and 2024 annual reports filed with the SEC to be “materially misstated,” such that they “should no longer be relied upon.”  Hub Group did not quantify the expected misstatement, although it “expect[ed] to conclude that it did not maintain effective disclosure controls and procedures and internal control over financial reporting for each of the years ended December 31, 2024 and 2023.”

This news caused the price of Hub Group stock to decline a further 13%, from $41.86 per share at close on May 11, 2026, to $36.62 per share at close on May 12, 2026.

Click here for more information:

https://www.bfalaw.com/cases/hub-group-class-action-lawsuit

.

What Can You Do?

If you invested in Hub Group, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/hub-group-class-action-lawsuit

Or contact:
Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.” 

Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/hub-group-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



IBM Investor Reminder: IBM Securities Fraud Investigation over 25% Stock Drop is Ongoing – Contact BFA Law if You Suffered Losses

BFA Law is investigating whether IBM committed securities fraud relating to misrepresentations about the pace of securing new business deals and the strength of its IBM Z product outlook.

NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into International Business Machines Corporation (NYSE:IBM) for potential securities fraud after its significant stock drop.

If you invested in IBM, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ibm-class-action-lawsuit.

Key Details of the IBM ($IBM) Class Action Investigation:

  • Investigation Overview: Securities fraud relating to IBM’s misrepresentations about the pace of securing new business deals and the strength of its IBM Z product outlook  
  • Stock Decline: July 14, 2026 – 25% Stock Drop
  • Action: Contact BFA Law to discuss your rights

Why is IBM Being Investigated for Securities Fraud?

IBM is being investigated for securities fraud following a significant stock drop. The decline in IBM’s stock price caused significant losses to investors.

IBM is a global technology and consulting company that focuses on hybrid cloud and artificial intelligence. IBM uses IBM Z to deliver enhanced AI acceleration through multi-model AI capabilities, low unit cost architecture at scale for workloads that require end-to-end encryption, continued availability, and ultra-high throughput.

BFA is investigating whether IBM misled investors about its pace securing new business deals and the strength of its IBM Z outlook.

Why did IBM’s Stock Drop?

On July 14, 2026, IBM released its 2026 Q2 financial results. IBM announced a disappointing quarter that it attributed to “a shortfall in our Z performance and the associated software stack, primarily in Transaction Processing.” IBM also revealed that it had “faltered,” and “did not adapt and move quickly enough” so that “numerous large deals failed to close on the timelines we expected, driving the majority of our shortfall.”

This news caused the price of IBM stock to decline over $75 in intraday trading on July 14, 2026, or over 25%.

Click here for more information:

https://www.bfalaw.com/cases/ibm-class-action-lawsuit

.

What Can You Do?

If you invested in IBM, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/ibm-class-action-lawsuit

Or contact:

Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”

Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/ibm-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



PLNT Investor Reminder: Planet Fitness Securities Fraud Class Action over 31% Stock Drop is Ongoing – Contact BFA Law before September 14 Deadline

A securities fraud class action lawsuit has been filed on behalf of Planet Fitness investors after its stock dropped over 31% relating to Planet Fitness’s failed marketing campaign that alienated the company’s core market, casual gym-goers, and led to disappointing membership growth during the key Q1 sign-up period.

NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Planet Fitness, Inc. (NYSE:PLNT) and certain of the Company’s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.

If you invested in Planet Fitness, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/planet-fitness-class-action-lawsuit.

Key Details of the Planet Fitness ($PLNT) Class Action Lawsuit:

  • Lead Plaintiff Deadline: September 14, 2026
  • Alleged Misconduct: Securities fraud relating to Planet Fitness’s failed marketing campaign that led to disappointing membership growth during the key Q1 sign-up period
  • Stock Drop: May 7, 2026 – 31% Stock Drop
  • Court: U.S. District Court for the District of New Hampshire
  • Take Action: Contact BFA Law to discuss your rights

Investors have until September 14, 2026, to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Planet Fitness common stock. The class action is pending in the U.S. District Court for the District of New Hampshire. It is captioned Matsunaga v. Planet Fitness, Inc., et al., No. 26-cv-00576.

Why is Planet Fitness Being Sued for Securities Fraud?

Planet Fitness is a large franchisor and operator of fitness centers across the United States. The company aims to offer a fitness experience in a non-intimidating environment, which it calls the Judgement Free Zone. 

The complaint alleges that throughout the relevant period, Planet Fitness misrepresented the success of its marketing campaign to focus on “fitness-minded” members. For instance, Planet Fitness told investors that it “continue[d] to lean into our ‘we are all strong on this Planet’ campaign.” Planet Fitness also stated that “[b]ecause this campaign resonated so strongly last year, we extended it into 2026.”

In truth, Planet Fitness’s marketing campaign alienated fitness beginners and more casual gym-goers, which traditionally had been the company’s focus and would be forced to restructure its marketing strategy. This caused the company to halt planned increases which its sales projections were premised on.

Why did Planet Fitness’s Stock Drop?

On May 7, 2026, Planet Fitness released its Q1 2026 financial results. The company announced disappointing membership growth and cut 2026 revenue growth guidance from approximately 9% to about 7% and adjusted EBITDA growth guidance from roughly 10% to approximately 6%. During the same-day earnings call, the company stated that its marketing “may have pivoted too far” as the company “shift[ed] from [its] lighthearted approachable tone” to one that “increased penetration with the fitness-minded.” As such it announced that, “we are pausing the planned national Black Card price increase pending a broader pricing review.”

This news caused the price of Planet Fitness stock to decline $19.95 per share, or 31%, from a closing price of $63.96 per share on May 6, 2026, to $44.01 per share on May 7, 2026.

Click here for more information:

https://www.bfalaw.com/cases/planet-fitness-class-action-lawsuit

.

What Can You Do?

If you invested in Planet Fitness, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/planet-fitness-class-action-lawsuit

Or contact:

Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.” 

Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/planet-fitness-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



CAPR Investor Reminder: Capricor Therapeutics Securities Fraud Class Action over 64% Stock Drop is Ongoing – Contact BFA Law before September 28 Deadline

Capricor Therapeutics, Inc. has been sued for securities fraud over alleged misstatements about Deramiocel and the integrity of the clinical data supporting its Biologics License Application leading to a 64% stock drop.

NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ:CAPR) and certain of the company’s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.

If you invested in Capricor Therapeutics securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/capricor-class-action-lawsuit.

Key Details of the Capricor Therapeutics ($CAPR) Class Action:

  • Lead Plaintiff Deadline: September 28, 2026
  • Lawsuit Allegations: Securities fraud alleging Capricor made false statements concerning Deramiocel and the integrity of the clinical data supporting its Biologics License Application.
  • Largest Alleged Stock Drop: July 27, 2026 – 64.5% Stock Drop
  • Court: U.S. District Court for the Southern District of California
  • Action: Contact BFA Law to discuss your rights

Investors have until September 28, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Capricor securities. The class action is pending in the U.S. District Court for the Southern District of California. It is captioned Nkamga v. Capricor Therapeutics, Inc. et al., No. 26-cv-04385.

Why is Capricor Being Sued for Securities Fraud?

Capricor is a biotechnology company focused on developing cell and exosome-based therapeutics for rare diseases. Its lead product candidate, Deramiocel, is an investigational cell therapy being developed for Duchenne muscular dystrophy.

According to the complaint, Capricor submitted a Biologics License Application to the FDA for Deramiocel in late 2024. In July 2025, the FDA issued a Complete Response Letter stating that the application did not meet the statutory requirement for substantial evidence of effectiveness and that additional clinical data was needed.

As alleged, Capricor failed to disclose that it adopted changes to the pre-specified statistical analysis plan used to analyze clinical data for Deramiocel and that the FDA had not agreed to those changes before Capricor resubmitted the Deramiocel BLA.

Why did Capricor’s Stock Drop?

On July 27, 2026, the FDA released briefing documents ahead of an advisory committee meeting concerning Deramiocel. The FDA briefing documents reportedly raised concerns about post-hoc changes to Capricor’s statistical analysis plan, including changes to the methodology for calculating the primary endpoint, PUL 2.0, shortly before the database was unlocked and unblinded. This news caused the price of Capricor stock to decline $12.70 per share, or 64.5%, from a closing price of $19.70 per share on July 24, 2026, to $7.00 per share on July 27, 2026, the following trading day.

On July 29, 2026, the FDA advisory committee met to discuss the Deramiocel BLA. The next day, a medical news website named Medscape reported that in a non-binding 9-3 vote, the panel concluded that available evidence did not support the efficacy of Deramiocel for treating DMD-associated cardiomyopathy. On this news, Capricor’s stock dropped $2.38 per share, or 36%, from a closing price of $6.57 per share on July 29, 2026, to $4.19 per share on July 30, 2026.

Click here for more information:

https://www.bfalaw.com/cases/capricor-class-action-lawsuit

.

What Can You Do?

If you invested in Capricor Therapeutics securities, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/capricor-class-action-lawsuit

Or contact:
Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”

Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/capricor-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



CCB Investor Reminder: Coastal Financial Securities Fraud Investigation over 43% Stock Drop is Ongoing – Contact BFA Law if You Suffered Losses

BFA Law is investigating whether Coastal Financial Corporation committed securities fraud relating to statements concerning the financial performance and credit quality of its banking as a service segment, including the company’s CCBX partner relationships.

NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coastal Financial Corp. (NASDAQ:CCB) for potential securities fraud after its significant stock drop.

If you invested in Coastal Financial securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/coastal-financial-class-action-lawsuit.

Key Details of the Coastal Financial ($CCB) Class Action Investigation:

  • Investigation Overview: Securities fraud investigation relating to the company’s statements concerning the credit quality and financial condition of Coastal Financial’s CCBX partner relationships and banking as a service segment
  • Stock Decline: July 30, 2026 – 43.5% Stock Drop
  • Action: Contact BFA Law to discuss your rights

Why is Coastal Financial Being Investigated for Securities Fraud?

Coastal Financial is a bank holding company based in Everett, Washington. The company provides banking as a service to digital financial service providers, companies, and brands that want to provide financial services to their customers through the bank’s CCBX segment.

BFA is investigating whether Coastal Financial misled investors about the financial performance and credit quality of its banking as a service segment, including the company’s CCBX partner relationships.

Why did Coastal Financial’s Stock Drop?

On July 30, 2026, Coastal Financial reported its Q2 2026 financial results. The company revealed a quarterly net loss of $42.1 million, or $(2.76) per diluted common share, compared to net income of $12 million, or $0.78 per diluted common share, the prior year. Coastal Financial stated that its net loss was driven by a $68.8 million credit expense related to an unnamed CCBX partner relationship.

This news caused the price of Coastal Financial stock to decline $30.75 per share, or 43.5%, from a closing price of $70.66 per share on July 29, 2026, to $39.91 per share on July 30, 2026.

Click here for more information:

https://www.bfalaw.com/cases/coastal-financial-class-action-lawsuit

.

What Can You Do?

If you invested in Coastal Financial securities, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/coastal-financial-class-action-lawsuit

Or contact:

Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”

Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/coastal-financial-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



GIL Investor Reminder: Gildan Securities Fraud Investigation over 18% Stock Drop is Ongoing – Contact BFA Law if You Suffered Losses

BFA Law is investigating whether Gildan committed securities fraud relating to allegations that the company engaged in a channel stuffing scheme to artificially inflate revenue.

NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Gildan Activewear Inc. (NYSE:GIL) for potential securities fraud after its significant stock drop.

If you invested in Gildan, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/gildan-class-action-lawsuit.

Key Details of the Gildan ($GIL) Class Action Investigation:

  • Investigation Overview: Securities fraud relating to allegations that Gildan engaged in a channel stuffing scheme to artificially inflate revenue
  • Stock Decline: June 16, 2026 – 18.75% Stock Drop
  • Action: Contact BFA Law to discuss your rights

Why is Gildan Being Investigated for Securities Fraud?

Gildan is being investigated for securities fraud following a significant stock drop. The decline in Gildan’s stock price caused significant losses to investors.

Gildan is an apparel manufacturer that produces and sells basic clothing—such as T-shirts, fleece, underwear, and socks—primarily in bulk to wholesalers, screen printers, and retailers.

BFA is investigating whether Gildan misled investors about its financial results, including the true drivers and sustainability of its reported revenue. For instance, Gildan attributed strong sales results to “share gains in key growth categories,” “strong market response to products introduced . . . which featured key innovations,” and other legitimate business factors.

Why did Gildan’s Stock Drop?

On June 16, 2026, Jehoshaphat Research published a report titled “Stuffing All of the Channel Some of the Time?” which alleged Gildan “has been stuffing the channel to make revenues look like they’re growing” and that “[t]his pulling-forward of sales has been cannibalizing future demand and inflating the overall growth trajectory of this business.” Jehoshaphat’s allegations are based on interviews with former employees, customers, and distributors, among other things.

This news caused the price of Gildan stock to decline $11.62 per share, or 18.75%, from a closing price of $61.97 per share on June 15, 2026, to $50.35 per share on June 16, 2026.

Click here for more information:

https://www.bfalaw.com/cases/gildan-class-action-lawsuit

.

What Can You Do?

If you invested in Gildan, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/gildan-class-action-lawsuit

Or contact:

Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”

Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/gildan-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



GTM Investor Reminder: ZoomInfo Securities Fraud Class Action over 33% Stock Drop is Ongoing – Contact BFA Law before August 24 Deadline

A securities fraud class action lawsuit has been filed on behalf of ZoomInfo investors after its stock plummeted nearly 33% because ZoomInfo allegedly misled investors regarding its customer retention

NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against ZoomInfo Technologies Inc. (NASDAQ:GTM) and certain of the Company’s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.

If you invested in ZoomInfo, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/zoominfo-class-action-lawsuit.

Key Details of the ZoomInfo ($GTM) Class Action:

  • Lead Plaintiff Deadline: August 24, 2026
  • Alleged Misconduct: Securities fraud alleging that ZoomInfo misled investors regarding the impact of ZoomInfo’s AI-integrated products on customer retention
  • Stock Drop: May 12, 2026 – 33% Stock Drop
  • Court: U.S. District Court for the Western District of Washington
  • Action: Contact BFA Law to discuss your rights

Investors have until August 24, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in ZoomInfo securities. The class action is pending in the U.S. District Court for the Western District of Washington. It is captioned Tejeda v. ZoomInfo Technologies et al., No. 26-cv-05696.

Why is ZoomInfo Being Sued for Securities Fraud?

ZoomInfo has been sued for securities fraud following a significant stock drop resulting from potential violations of the federal securities laws. The decline in ZoomInfo’s stock price caused significant losses to investors.

ZoomInfo provides go-to-market (“GTM”) intelligence and a customer engagement platform for sales, marketing, operations, and recruiting professionals.

Throughout the relevant period, ZoomInfo allegedly stated that “the demand for AI for GTM is evident up and down our customer stack.” According to ZoomInfo, its “innovative go-to-market AI” was “driving stronger daily engagement from a diverse set of go-to-market personas.”

On February 9, 2026, ZoomInfo issued its 2026 revenue guidance “in the range of $1.247 billion to $1.267 billion,” because “in 2026, our focus is on bringing” ZoomInfo’s “all-in-one AI platform for go-to-market teams . . . to our customers at scale.”

As alleged, ZoomInfo’s customer retention declined as customers were rejecting ZoomInfo’s AI products.

Why did ZoomInfo’s Stock Drop?

On May 11, 2026, ZoomInfo announced its Q1 2026 results and slashed its 2026 revenue guidance from $1.247-$1.267 billion to $1.185-$1.205 billion. ZoomInfo revealed that its customer growth “regressed” due to “AI and agentic confusion” leading to “a pause in [customers’] purchasing decisions[.]”

This news caused the price of ZoomInfo stock to decline $1.98 per share, or 32.78%, from a closing price of $6.04 per share on May 11, 2026, to $4.06 per share on May 12, 2026.

Click here for more information:

https://www.bfalaw.com/cases/zoominfo-class-action-lawsuit

.

What Can You Do?

If you invested in ZoomInfo, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/zoominfo-class-action-lawsuit

Or contact:
Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.”  One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”

Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/zoominfo-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.



UWMC Investor Reminder: UWM Holdings Securities Fraud Class Action over 34% Stock Drop is Ongoing – Contact BFA Law before October 13 Deadline

UWM has been sued for securities fraud after its stock plummeted 34.78% because UWM allegedly misrepresented its mortgage servicing rights hedging strategy and the risks created by hedging connected to the Two Harbors transaction.

NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against UWM Holdings Corporation (NYSE:UWMC) and certain of the company’s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.

If you invested in UWM, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/uwm-holdings-class-action-lawsuit.

Key Details of the UWM ($UWMC) Class Action:

  • Lead Plaintiff Deadline: October 13, 2026
  • Alleged Misconduct: Securities fraud alleging that UWM misrepresented its mortgage servicing rights hedging strategy and the risks created by hedging connected to the Two Harbors transaction
  • Stock Drop: August 6, 2026 – 34.78% Stock Drop
  • Court: U.S. District Court for the Eastern District of Michigan
  • Action: Contact BFA Law to discuss your rights

Investors have until October 13, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in UWM securities. The class action is pending in the U.S. District Court for the Eastern District of Michigan. It is captioned Bond v. UWM Holdings Corporation et al., No. 26-cv-12862.

Why is UWM Being Sued for Securities Fraud?

UWM originates, sells, and services residential mortgage loans in the United States. In December 2025, UWM and Two Harbors Investment Corp., owner of RoundPoint Mortgage Servicing, signed an all-stock merger agreement valued at $1.3 billion.

According to the complaint, in March 2026, Two Harbors terminated the UWM agreement after CrossCountry Mortgage made a competing cash offer and agreed to pay UWM’s termination fee.

As alleged, UWM failed to disclose that it had deviated from its traditional strategy of not hedging its mortgage servicing rights by taking a major hedge position, that it over-hedged itself in anticipation of the Two Harbors transaction, and that its purported efforts to balance risk created excess hedging risk.

Why did UWM’s Stock Drop?

On August 5, 2026, after the market closed, UWM reported Q2 2026 financial results, including a $603.2 million interest rate derivatives loss which contributed to a $451.9 million second-quarter net loss. Total equity also fell 43.6% year over year, reflecting the net loss and derivative-related charges.

Then, on August 6, 2026, UWM disclosed that it “over-hedged” while protecting against the Two Harbors transaction and stated that UWM does not traditionally hedge its mortgage servicing rights. UWM further disclosed that when it was acquiring Two Harbors and a large mortgage servicing rights book, “it created a little more risk,” that UWM “did put a hedge on to protect against that risk,” and that “the Two Harbors transaction went away,” creating a hedge loss. On this news, UWM’s stock dropped $0.64 per share, or 34.78%, from a closing price of $1.84 per share on August 5, 2026, to $1.20 per share on August 6, 2026.

Click here for more information:

https://www.bfalaw.com/cases/uwm-holdings-class-action-lawsuit

.

What Can You Do?

If you invested in UWM, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:


https://www.bfalaw.com/cases/uwm-holdings-class-action-lawsuit

Or contact:
Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360, and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.”  One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”

BFA’s notable successes include a recovery of over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.


https://www.bfalaw.com/cases/uwm-holdings-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.